Thursday, March 05, 2020
13th Annual “Celebrating Diversity” Dinner Supports Student Scholarships
UMSOM Award Recipients Honored for Promoting Health Equity and Career Advancement for Underrepresented Groups
Thursday, March 05, 2020
Preventing COVID-19 (coronavirus) in Maryland Hospitals:
Hospital epidemiologists are doctors who prevent infections. World leaders in hospital epidemiology and infectious disease prevention, the physicians and scientists based in the Division of Genomic Epidemiology and Clinical Outcomes (GECO) at the University of Maryland School of Medicine are preparing our healthcare system for COVID-19 and COVID-19 transmission prevention.
Thursday, February 27, 2020
UMSOM Department of Psychiatry Creates New Position to Strengthen and Support Research Program
Jill RachBeisel, MD, Interim Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Gloria Reeves, MD, Associate Professor of Psychiatry, has been appointed to serve as the Vice Chair for Research of the Department.
Wednesday, February 26, 2020
Dr. Rajabrata Sarkar Appointed Director of Faculty Group Practice Operations at the University of Maryland School of Medicine
University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, along with Anthony F. Lehman, MD, MSPH, Senior Associate Dean for Clinical Affairs at UMSOM, announced today that Rajabrata (Raj) Sarkar, MD, a leading vascular surgeon at UMSOM who is the Barbara Baur Dunlap Professor in Surgery, has been appointed Director of Faculty Group Practice Operations for the UMSOM.
Wednesday, February 26, 2020
Researchers Develop First Catalogue of Genes that Comprise Community of Microbes in Vaginal Microbiome
University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) researchers have created the first catalogue of genes that comprise the community of microbes, which inhabit the human vagina. The catalogue, called human vaginal non-redundant gene catalog (VIRGO), was recently released as a public resource that can be used by researchers to facilitate a more in-depth understanding of the role of vaginal microorganisms in women’s health and to potentially develop future treatments for certain gynecologic conditions.
Wednesday, February 26, 2020
UMSOM’s Office of Student Affairs Names Dr. Kristin Reavis as Director of Student Diversity and Inclusion, and Dr. Constance Lacap as Assistant Dean for Assessment
University of Maryland School of Medicine (UMSOM) Senior Associate Dean for Undergraduate Medical Education, Donna Parker, MD, FACP, along with Dean E. Albert Reece, MD, PhD, MBA, today announced two appointments that will further enhance the quality of medical education at the UMSOM. Kristin Reavis, MD, Assistant Professor of Family and Community Medicine, has been named Director of Student Diversity and Inclusion in the Office of Student Affairs, while Constance N. Lacap, DO, Assistant Professor of Psychiatry, has been named Assistant Dean for Assessment in the Office of Medical Education.
Tuesday, February 25, 2020
World Health Organization Names UMSOM Faculty Member as COVID-19 Advisor
Samba Sow, MD, MSc, FASTMH, Director General of the Center for Vaccine Development in Mali (CVD-Mali), and Adjunct Professor of Medicine at the University of Maryland School of Medicine (UMSOM), was appointed by the World Health Organization (WHO) to serve as a special envoy on issues related to coronavirus COVID-19.
Tuesday, February 25, 2020
Experimental Treatment That Resets Immune Cells Markedly Improves Recovery from Traumatic Brain Injury
Researchers at the University of Maryland School of Medicine (UMSOM) found that targeting overactive immune cells in the brain with an experimental drug could limit brain cell loss and reverse cognitive and motor difficulties caused by traumatic brain injury (TBI). The findings, published Monday in the Journal of Neuroscience, suggest a potential new treatment for TBI and possibly other brain injuries.
Tuesday, February 25, 2020
Washington Post Visits UM School of Medicine Laboratories, Meets with Scientists About Coronavirus
Result is front-page feature coverage of UMSOM’s leading work in studying the Virus
Monday, February 24, 2020
Institute of Human Virology and OncoImmune Launch Clinical Trial to Lessen Effects of HIV Later in Infection
On February 1, the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and OncoImmune, Inc. launched a new Phase II clinical trial called CALIBER, which will test whether OncoImmune’s lead product, CD24Fc, can reduce late effects of HIV infection, such as inflammatory abnormalities including cardiovascular disease. This is intended for use in HIV patients who have been receiving the traditional antiretroviral therapies that control, but do not cure, HIV infection.